Effectiveness of daily and weekly iron supplementation

Comparative experimental study of the effectiveness of daily and weekly iron supplementation in the prevention of anemia in 1 year old infants

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

TCTR

Registry ID

TCTR20150824001

Enrollment

128

Registered

2015-08-24

Start date

2015-09-17

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anemia in infant Anemia in Infant

Interventions

12.5 mg ferrous fumarate weekly,12.5 mg ferrous fumarate daily

Sham Comparator Drug,Experimental Drug

12.5 mg ferrous fumarate ,12.5 mg ferrous fumarate

Eligibility

Sex/Gender

All

Age

5 Months to 7 Months

Inclusion criteria

Inclusion criteria: 1) age 5-7 months 2) can swallow ferrous fumarate oral suspension 3) parents are willing to follow the studied protocal 4) can be followed up at 1 year old or 6 month

Exclusion criteria

Exclusion criteria: 1) presents thalassemia 2) has history of cardiology, respiratory, gastrointestinal diseases, or other diseases that can be obstacle to the study 3) has history of sensitivity or reaction to ferrous fumarate 4) on medication that reacts to ferrous fumarate

Design outcomes

Primary

Measure	Time frame
Prevalence of anemia 6 months after receiving ferrous fumarate Hemocue Hb 201+	—

Secondary

Measure	Time frame
Drug adherence 6 months after receiving ferrous fumarate questionnaire	—

Contacts

Public ContactWicharn Luesomboon

QueenSVMH

luesomboon@gmail.com+66038320200

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026